NASDAQ:IBB

Ishares Nasdaq Biotechnology Index Fund ETF News

etoro logo Buy IBB
*Your capital is at risk
$178.09
+1.09 (+0.616%)
At Close: Jun 23, 2026
ValuEngine upgraded shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning, ValuEngine reports. Shares
Over the last three weeks, the M2 money supply has exploded by a whopping $532 billion. Money supply is expanding at 26x the rate of QE1 during the 2008 financial crisis.
Fulton Bank N.A. lifted its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange
Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE